Remove category press-releases
article thumbnail

Competitive Intelligence Analytics

Fuld

Tracking financials, press releases, product launches, key developments, news mentions, employment trends, engagement trends from social media, and more. Track and stay ahead of your competition through automated KPI and news feeds visualized in dynamic dashboards. Company-specific data. Industry-specific metrics.

52
article thumbnail

Oral PCSK9 inhibitor MK-0616 significantly lowers LDL cholesterol

Hospital Pharmacy Europe

The current press release relates to the findings from a phase 2b clinical trial in which MK-0616 was given at varying doses (6, 12, 18 and 30mg) to adult patients with hypercholesterolaemia and who were divided into one of three categories, in which fasting LDL cholesterol levels ranged from > 1.81 to < 6.48

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Despite ban, Martin Shkreli can’t seem to kick the pharma habit

pharmaphorum

” That is certainly a departure from Shkreli’s earlier efforts to disrupt the healthcare category by inflating the price of critical HIV medication Daraprim by around 5,000% when he was chief executive at Turing Pharma. .”

article thumbnail

The Impact of AmazonSmile Ending

BuzzRx

But as Amazon said in their press release, “A fter almost a decade, the program has not grown to create the impact that we had originally hoped. Our nonprofit partners are in distinct, non-competing categories unified by their health-related missions in order to amplify our impact.

article thumbnail

Top 20 Nutraceutical Companies Based on 2022 Segment Revenue 

PharmaShots

The business sells nutraceutical products under categories, including Children's Health Supplements, Skin, Hair & Nails Supplements, and Immune Supplements. General Health, Immune, Cardiovascular, Digestive, Personal Care, and Weight Management are among the categories under which the company operates. Revenue: $548.3M

article thumbnail

Expanding ketamine’s horizons to treat rare neurological disorders

Pharmaceutical Technology

According to PharmatTher’s November 14 press release, all 10 patients in the Phase I/II trial reported a reduction in dyskinesias after receiving ketamine. Substances in this category have an approved medical use in the US, but can result in low or moderate physical dependence or high psychological dependence.

article thumbnail

Remicade alternatives: What can I take instead of Remicade?

The Checkup by Singlecare

In addition, Remicade falls under the larger category of biologics, a term under the umbrella of immunosuppressants. As we break the categories down to specific drugs, your options become more clear. Xeljanz XR (extended-release tofacitinib). You would be hard-pressed to find a difference between Renflexis and Remicade.